As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Endoscopic gastric remodeling reduced GERD symptoms and dependence on proton pump inhibitors in patients with obesity, according to a new study.

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...

Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...

Sarcopenic obesity, a hidden condition affecting people over 40, causes muscle loss and fat gain without major weight changes ...

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks.

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Also, people with obesity might have a normal — or even a higher — total amount of muscle than average, but the muscle itself often isn’t as healthy or as strong as it needs to be. Issues ...